Atlas Trials

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

Clinical trial NCT07146672 · RECRUITING

Trial details

NCT number
NCT07146672
Sponsor
Shanghai Cell Therapy Group Co.,Ltd
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Solid Tumor Cancer
Start date
2025-07-31
Primary completion
2026-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.